Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.12 - $0.64 $5,068 - $27,034
42,241 Added 124.6%
76,141 $16,000
Q3 2023

Nov 13, 2023

BUY
$0.12 - $0.41 $4,068 - $13,899
33,900 New
33,900 $4,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $124M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.